Maximilian Kleinert serves as an Assistant Professor in the Department of Nutrition, Exercise and Sports at the University of Copenhagen, specifically within The August Krogh Section for Molecular Physiology. His research integrates molecular physiology with nutritional science to address metabolic health challenges. His primary research interests focus on metabolism , nutritional biochemistry , and exercise physiology , with particular emphasis on medium-chain fatty acids, skeletal muscle substrate utilization, and hormonal regulation. Current investigations explore how dietary interventions influence metabolic pathways in obesity and exercise contexts, utilizing both human and molecular models. Analysis of his recent publications reveals a strong thematic focus on medium-chain triglycerides and their metabolic effects, hepatic fat regulation through CREBH-FGF21 signaling, and innovative dairy processing techniques to enhance metabolic health outcomes. His work bridges fundamental molecular mechanisms with translational nutritional applications. Kleinert actively collaborates across international research networks, with publications appearing in high-impact journals including Nature Communications , American Journal of Physiology , and Trends in Endocrinology and Metabolism . His research group within The August Krogh Section employs advanced methodologies in molecular physiology and nutritional interventions to address metabolic disorders.
Mohammad Roghanian is a Guest Researcher at the Department of Biology, Functional Genomics section, University of Copenhagen. His research focuses on molecular mechanisms of bacterial stress response, particularly the stringent response mediated by (p)ppGpp signaling in bacteria like Escherichia coli. Dr. Roghanian's primary research interests include: Stringent response regulation in bacteria (p)ppGpp alarmone signaling pathways Toxin-antitoxin systems and their role in stress adaptation Molecular basis of bacterial persistence RelA enzyme function and regulation Ribosome-mediated stress sensing mechanisms Analysis of Dr. Roghanian's publications from 2015-2019 reveals a cohesive research program examining how bacteria sense and respond to environmental stresses through the stringent response pathway. His work demonstrates how (p)ppGpp signaling connects various stress conditions—including nutrient starvation, membrane defects, and translational challenges—to global changes in bacterial physiology. A significant portion of his research investigates the molecular mechanisms by which HipA and related toxins interact with the stringent response to generate persister cells. Dr. Roghanian has established productive collaborations with Professor Kenn Gerdes and other researchers at the University of Copenhagen. His work has been published in high-impact journals including Molecular Cell, Proceedings of the National Academy of Sciences, and mBio, with several papers receiving substantial citation counts, particularly his research on persister cell formation.
Michal Poborsky is a Research Fellow at the Department of Plant and Environmental Sciences within the Faculty of Science at the University of Copenhagen. His work focuses on engineering microbial systems for sustainable production of plant-derived compounds, operating under the Section for Molecular Plant Biology. Education PhD in Biotechnology from University of Copenhagen (awarded July 2022), thesis: Engineering Escherichia coli towards production of plant specialized metabolites His research integrates metabolic engineering, synthetic biology, and enzyme design to optimize microbial cell factories. Key expertise includes cytochrome P450 expression in Escherichia coli , benzylglucosinolate pathway engineering in Saccharomyces cerevisiae , and rational redesign of hydratases for enhanced substrate specificity. His methodologies address critical challenges in heterologous metabolite production, including enzyme functionality, transport engineering, and pathway compartmentalization. Analysis of his 2020-2023 publications reveals a cohesive trajectory in microbial engineering for plant metabolite synthesis. Dominant themes include cytochrome P450 functionality in bacterial systems (2023), comparative pathway engineering in yeast (2022), and precision enzyme engineering for regioselectivity control (2020-2021). These works collectively advance sustainable bioproduction of high-value phytochemicals through innovative strain and pathway design. No scientific awards are documented in the provided materials. While no formal advising roles or grant funding are specified, his collaborative network includes prominent researchers such as Barbara Ann Halkier, Carl Crocoll, and Morten S. Motawie across 5 of his 6 publications. His work has been referenced in 1 patent and garnered significant academic attention with 108 total Mendeley readers. Poborsky operates within the molecular plant biology research group led by Professor Barbara Ann Halkier at Thorvaldsensvej 40, Frederiksberg. His laboratory work centers on microbial strain development, with experimental focus on E. coli and yeast platforms for plant metabolite biosynthesis, leveraging techniques in genetic engineering, enzyme kinetics, and metabolic flux analysis.
David Brian Collinge is Professor of Plant Pathology at the Department of Plant and Environmental Sciences (PLEN), Faculty of Science, University of Copenhagen. Since 2023, he has served as Head of the Section for Microbial Ecology and Biotechnology, overseeing approximately 40 employees across 4 research groups. Previously, he was Head of the Section for Plant Pathology from 2003-2006. His academic journey began with a BSc in Genetics from the University of Liverpool (1979) followed by a PhD in Genetics from the University of Newcastle Upon Tyne (1982). Professor Collinge's research focuses on the nature of plant defense mechanisms, pathogenicity mechanisms, signal sensing and transduction in plants, and the exploitation of these mechanisms for disease control in developing countries. His work extensively examines fungal interactions with plants across various lifestyles including necrotrophs, biotrophs, and endophytes. His research group has worked with multiple biological systems involving fungal pathogens since 1988, including studies on Pea with Ascochyta pisi, Rape with Leptosphaera maculans, Wheat with Septoria tritici and Fusarium graminearum, Maize with Maize Rayado Fino Virus, and Norway Spruce with Ceratobasidium bicorne. The bulk of his research effort has concerned Barley with the Powdery Mildew Fungus (Blumeria graminis) and Fusarium graminearum. His recent publications (2022-2025) reveal a strong focus on fungal endophytes for plant disease control, particularly examining the interactions between beneficial fungi and cereal crops to combat Fusarium diseases. His work demonstrates how endophytic fungi can activate plant defense mechanisms to suppress pathogens, with significant implications for sustainable agriculture. His research spans molecular mechanisms of plant-microbe interactions, mycotoxin detoxification pathways, and the development of biological control strategies as alternatives to chemical pesticides. NOVA Prize (2008) for Nordic MSc programme in Plant Pathology President of BSPP (2022) Joint Editor in Chief of CABI Plant Health Cases (since 2022) Associate Editor for European Journal of Plant Pathology (since 2004) and Plant Pathology (since 2011) Professor Collinge has supervised 31 completed PhD students and has been responsible for 4 PhD courses and 2 BSc/MSc level courses in plant biotechnology and plant pathology. He has participated in acquiring over 100 million Danish Kroner for research funding, including coordination of several major research programs such as the Marie S. Curie Horizon 2020 ETN "BestPass" (2015-2019) and Danida FFU projects on Black Sigatoka in banana. His leadership extends to being Coordinator for Denmark for Nordic PhD courses in plant pathology (2001-2017) and serving on numerous national and international examination boards and review committees. His research group, the "Plant Pathology and Microbiology" group, has maintained up to 10 employees since 1988 and has established collaborations across multiple continents, with visiting professorships at McGill University, Huazhong Agricultural University, and University of Pretoria. The group's current focus on endophytic fungal interactions aims to uncover defining principles in crop protection and plant tolerance across biotic and abiotic stresses, with potential applications for sustainable food security worldwide.
Henrik Clausen is a Professor in the Department of Cellular and Molecular Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences. He leads the Copenhagen Center for Glycomics and is actively engaged in developing innovative technologies to advance the field of glycomics. His work focuses on transforming glycosciences from a specialist field into a mainstream 'Omics' discipline comparable to genomics and proteomics. Dr. Clausen earned his DDS in 1981 and Dr.odont (D.Sc.) in 1990, both from the School of Dentistry, Faculty of Health Sciences at the University of Copenhagen. His academic journey includes positions at the University of Washington in Seattle and the Biomembrane Institute, before returning to Copenhagen where he became Professor at the Institute of Cellular and Molecular Medicine in 2005. His primary research focuses on glycans that coat proteins in nature, with particular expertise in blood type conversion (transforming blood types A, B, and AB to blood type O) and cancer biomarkers. Through projects like GlycoDisplay, GlycoCRISPR, GlycoDesign, and GlycoView, his laboratory develops tools and community resources to make glycoscience more accessible to non-specialists. His current research includes a Lundbeck Foundation-funded program (2017-19) to develop a cell-based platform displaying all human glycans for high-throughput screening. Analysis of his recent publications reveals a strong focus on glycan-protein interactions, particularly in cancer and infectious disease contexts. His work spans structural biology, enzymology, and cell signaling, with applications in immunology, virology, and oncology. The research demonstrates how glycosylation affects receptor function, cell signaling, and pathogen-host interactions, with significant implications for therapeutic development. The Benzow Prize (1994) The Thureus Prize (1998) Mizutani Prize (1999) The Carlsberg Biotechnology Prize (2008) Professor Clausen serves on the editorial boards of Glycoconjugate Journal (since 1995) and Journal of Biological Chemistry (since 2004). He has organized numerous international conferences including Benzon Symposia, Nordic Glycobiology Symposia, and International Glycosyltransferase Symposia. His industry collaborations include advisory roles at Aptein Inc, Neose Inc, ZymeQuest Inc, and Millennium Pharmaceuticals. He directs the Copenhagen Center for Glycomics, which develops extensive glycopeptide libraries representing cancer-associated glycoforms of membrane glycoproteins. These libraries are printed on microarray slides to detect antibodies against cancer antigens in patient samples, with the goal of identifying autoantibody signatures as sensitive and specific cancer markers.
Mark Smits is a postdoctoral researcher at the University of Copenhagen's Faculty of Health and Medical Sciences, Department of Biomedical Sciences, working within Professor Jens Juul Holst's research group focused on endocrinology and metabolism. His academic journey began with medical training in Amsterdam where he earned both Bachelor's and Master's degrees with honors from Vrije Universiteit Amsterdam. Medical Doctor (MD) qualification from Amsterdam PhD in gut-hormone based therapies from Vrije Universiteit Amsterdam (completed with honors) Current endocrinology specialist training Dr. Smits' research centers on gut hormone physiology, particularly mechanisms to enhance glucagon-like peptide-1 (GLP-1) secretion. His work spans molecular mechanisms of hormone secretion, dietary influences on metabolic pathways, and therapeutic applications for diabetes and metabolic disorders. Recent publications demonstrate expertise in incretin biology, gut-brain axis signaling, and translational approaches to metabolic disease. His collaborative research network spans multiple international institutions, with significant contributions to understanding GLP-1 secretion pathways, nutrient-hormone interactions, and metabolic adaptations in disease models. Dr. Smits has published over 65 peer-reviewed articles, with recent work appearing in high-impact journals including Diabetes , American Journal of Physiology , and Diabetes/Metabolism Research and Reviews . As part of Holst's renowned research group, he contributes to cutting-edge investigations into gut hormone-based therapies while advancing his clinical training in endocrinology. His dual expertise in clinical medicine and basic research positions him at the intersection of translational endocrinology and metabolic disease therapeutics.
Nanna Bjarnholt is an Associate Professor in the Department of Plant and Environmental Sciences at the University of Copenhagen's Faculty of Science, where she leads the Plant Metabolic Plasticity Group. Her research focuses on plant specialized metabolites, particularly cyanogenic glycosides and glutathione transferase enzymes, using advanced mass spectrometry imaging and metabolomics techniques. Dr. Bjarnholt earned her MSc in Environmental Chemistry (2003) and PhD in Plant Biochemistry (2007), both from the University of Copenhagen. After completing postdoctoral work at the Department of Plant Biology and Biotechnology (2008-2014), she was appointed Associate Professor in 2014 and became a Research Group Leader in 2018. Her research primarily investigates the physiological roles and catabolism of cyanogenic glycosides in plants like sorghum, Lotus japonicus, cassava, barley, and almond. A significant discovery from her work revealed that glutathione transferase enzymes (GSTs) catalyze a reductive cleavage reaction in a pathway for nitrogen recovery from cyanogenic glucosides. With funding from the VILLUM Foundation, her group focuses on uncovering additional GST functions in plant specialized metabolism. She has pioneered the application of mass spectrometry imaging to visualize metabolite distribution and enzymatic conversion in plant tissues. Analysis of her recent publications shows a consistent focus on plant specialized metabolism, particularly cyanogenic compounds and glutathione transferases. Her work spans fundamental biochemistry to crop science applications, with increasing emphasis on mass spectrometry imaging techniques. Recent research has expanded to include Cannabis sativa metabolite distribution, sorghum transformation methods, and plant-pathogen interactions. Dr. Bjarnholt has secured significant research funding, including a VILLUM Young Investigator grant (10 million DKK), a Semper Ardens grant from The Carlsberg Foundation (19 million DKK), and multiple other competitive grants totaling over 40 million DKK. Her research has resulted in 61 publications with substantial citations and international recognition. She currently supervises 4 PhD students (with 6 completed) and 1 postdoc (with 2 past), teaching B.Sc. level courses in biochemistry, metabolomics, and Mass Spectrometry Imaging. Her international collaborations include researchers from Newcastle University, University of Illinois, University of Queensland, University of Lausanne, and others. Dr. Bjarnholt serves on the Copenhagen Plant Science Center scientific committee and the departmental research committee, demonstrating her leadership within the academic community.
Ernst Stefan Seemann serves as an Associate Professor in the Department of Veterinary and Animal Sciences within the Faculty of Health and Medical Sciences at the University of Copenhagen. His research focuses on non-protein coding RNAs (ncRNAs) and RNA structure functionality, utilizing advanced methodologies including RNA structure modeling, prediction of RNA-RNA and protein-RNA binding, and analysis of next-generation sequencing data. His primary research interests encompass: Non-protein coding RNAs (ncRNAs) and RNA structure biology Next-generation sequencing and single-cell RNA-seq analysis Comparative genomics and prediction/annotation of ncRNAs Host-pathogen RNA interactions Stem cell models for neurodegenerative diseases Seemann is actively involved in multiple high-impact research initiatives including investigations of novel ncRNAs in bacteria (NextProd project), animal ncRNAs (FAANG consortium), host-virus RNA-RNA interactions with Assoc Prof Troels KH Scheel, single-cell RNA sequencing in neurogenesis studies with Assoc Prof Vanessa J Hall, and transcriptomics in stem cell models for neurodegenerative diseases (NeuroStem project). His publication record demonstrates strong interdisciplinary collaboration across computational biology, veterinary science, and medical research. His scientific contributions span environmental microbiology, gene therapy, neuroscience, and computational biology, with recent work focusing on CRISPR applications, CAR T-cell engineering, microglial metabolism in dementia, and metabolic engineering of bacterial systems. His research has been cited across multiple platforms including academic journals, Mendeley readership, Wikipedia, and news outlets.
Frederik Friis Theisen is a Postdoctoral Researcher in the Department of Biology at the University of Copenhagen, specializing in Biomolecular Sciences within the Faculty of Science. He conducts research at Ole Maaløes Vej 5, Copenhagen, focusing on the molecular mechanisms of protein function and regulation. Dr. Theisen completed his PhD in 2022 with a dissertation titled "The Behaviour of Short Linear Motifs in the DREB2A Transcription Factor and the Effect of Molecular Context" through the Department of Biology, Faculty of Science, University of Copenhagen. His research program centers on intrinsically disordered proteins, transcription factors, and stress response pathways in plants, with particular emphasis on how conformational dynamics—especially proline isomerization—regulates protein interactions and transcriptional activity. Dr. Theisen employs biophysical, biochemical, and computational approaches to investigate molecular recognition processes at the atomic level, revealing fundamental mechanisms of cellular adaptation to environmental stresses. Analysis of Dr. Theisen's publication record shows a cohesive research trajectory exploring protein dynamics across multiple biological contexts. His work bridges molecular biology, structural biology, and plant science, with recent publications in high-impact journals including Nature, Nature Communications, and Journal of the American Chemical Society demonstrating the significance of his contributions to understanding protein conformational changes and their biological implications. Dr. Theisen maintains an active collaborative network with researchers including Birthe B. Kragelund, Karen Skriver, and Anders D. Due at the University of Copenhagen. His research has garnered significant attention in the scientific community, with multiple papers widely shared on academic social media platforms and receiving substantial readership on research networking sites like Mendeley. His 2024 Nature paper on stereochemistry in protein interactions represents a particularly influential contribution that has been referenced by over 100 Bluesky users and read by numerous researchers worldwide.
Feiyan Liang serves as an Assistant Professor in the Department of Plant and Environmental Sciences at the University of Copenhagen, specializing in the Section for Plant Biochemistry. Her research integrates biochemical, enzymatic, and metabolic approaches to investigate critical plant processes with biotechnological applications. Her core research domains include: Plant Biochemistry and Natural Product Biosynthesis Photosynthetic Mechanisms and Regulation Metabolic Engineering of Plant Pathways Enzymology of Cytochrome P450 Systems Metabolic Flux Analysis in Microorganisms Current investigations focus on elucidating taxol biosynthesis pathways for anti-cancer drug development and dissecting Photosystem II water-access channels through advanced mutagenesis and mass spectrometry techniques. Her work demonstrates strong interdisciplinary collaboration across biochemistry, biophysics, and synthetic biology, targeting both fundamental mechanisms and biotechnological applications in plant systems. Dr. Liang maintains active research output with publications in high-impact journals including Nature Synthesis, Journal of the American Chemical Society, and Photosynthesis Research, reflecting significant contributions to plant biochemistry and metabolic engineering fields.
Jan Halborg Jensen is a Professor in the Department of Chemistry at the University of Copenhagen, with a distinguished research career in computational chemistry and molecular modeling. His work spans quantum chemistry, cheminformatics, and machine learning applications in chemical research, with significant contributions to drug design, catalyst discovery, and chemical reaction prediction. His primary research interests focus on Computational Chemistry , Molecular Modeling , and Quantum Chemistry , with particular expertise in applying machine learning techniques to chemical problems. Jensen's research integrates computational methods with practical chemical applications, including retrosynthesis planning, catalyst design, and drug discovery. His work bridges theoretical chemistry with practical applications in organic synthesis and pharmaceutical development. Analysis of Jensen's recent publications (2023-2025) reveals a strong focus on machine learning applications in chemistry, particularly for predicting chemical reactivity, designing catalysts, and advancing drug discovery. His work demonstrates increasing integration of artificial intelligence with traditional computational chemistry methods, with significant contributions to cheminformatics, transition metal chemistry, and biomolecular simulation standards. The research spans theoretical developments and practical applications across organic chemistry, biochemistry, and materials science. Jensen maintains an active research program with extensive publication output, including 88 research contributions comprising journal articles, book chapters, and books. His work shows strong collaborative networks across computational chemistry and related fields. He has presented on educational technology topics, including a lecture titled "Make a difference - teach and learn with technology" in April 2018, demonstrating engagement with pedagogical developments alongside research activities. His online presence includes a professional blog (molecularmodelingbasics.blogspot.com) and comprehensive CV documentation.
Mette Homann Poulsen serves as an Assistant Professor in the Department of Drug Design and Pharmacology at the University of Copenhagen, with additional affiliation as a Guest Researcher in the Biopharmaceuticals section of the same department. Her research bridges molecular pharmacology and drug design with a focus on ion channel mechanisms. Her primary research interests span Ion Channel Pharmacology , Receptor Biology , and Molecular Pharmacology , particularly investigating P2X and AMPA receptor families. Her work examines pH-sensing mechanisms, transporter-channel crosstalk, and receptor variants in disease contexts including cancer and mental disorders. She employs techniques ranging from protein engineering to cellular electrophysiology to develop pharmacological tools and understand disease mechanisms. Analysis of her recent publications (2018-2025) reveals a strong emphasis on receptor variant functionality, with significant contributions to understanding P2X7 receptor polymorphisms in pancreatic cancer and mental health disorders. Her work integrates biophysical approaches with disease modeling, demonstrating translational potential in oncology and neuroscience. No scientific awards were explicitly mentioned in the source material. Dr. Poulsen maintains active collaborations with researchers including S.A. Pless, N.R. Jørgensen, and I. Novak across multiple institutions. Her research has attracted substantial attention, with publications generating significant Mendeley readership and social media engagement, particularly her 2020 Nature Communications paper which garnered 117 Mendeley readers and 17 social media interactions. While specific laboratory or team structures weren't detailed in the source material, her publication patterns suggest active participation in interdisciplinary research groups focusing on receptor pharmacology and protein engineering within the Department of Drug Design and Pharmacology.
Leila Lo Leggio is a Professor in the Department of Chemistry at the University of Copenhagen, Faculty of Science. She has been a professor since March 2018, previously serving as an Associate Professor from August 2003 to February 2018. She leads research in structural biology and enzymology, with a focus on carbohydrate-active enzymes and protein structure-function relationships. She is a member of the ISBUC Structural Biology and Medicinal Chemistry clusters at the University of Copenhagen and has authored 186 PDB entries. Her educational background includes: First class Honours Degree from the University of Bath, UK (1993), with professional placements at Babraham Institute, Cambridge, UK and Max-Planck Institute, Martinsried, München, Germany PhD obtained at Institute of Food Research, Reading, UK/Birkbeck College, London (1997) Professor Lo Leggio's research focuses on the structure-function relationship in proteins, with recent emphasis on carbohydrate-active proteins, DNA-binding transcription factors, and protein engineering/design. Her work primarily employs X-ray crystallography and small angle scattering techniques to investigate enzyme mechanisms, particularly lytic polysaccharide monooxygenases (LPMOs) and other biomass-degrading enzymes. Her research has significant implications for biomass conversion, sustainable chemistry, and industrial biotechnology applications. Her recent publications demonstrate a strong focus on understanding the molecular mechanisms of carbohydrate-active enzymes, particularly lytic polysaccharide monooxygenases and glucuronoyl esterases. Her work spans structural characterization, enzyme engineering, and applications in biomass conversion and sustainable technologies. A notable trend is the increasing interdisciplinary nature of her research, combining structural biology with quantum chemistry calculations and practical biotechnology applications, particularly in sustainable textile dyeing and biomass utilization. Professor Lo Leggio has secured significant research funding, including multiple grants from the Danish Independent Research Fund and Novo Nordisk Foundation. Her current projects include: DFF FTP grant 'HIPPO' (2025-2030, 6.2 million DKK) DFF FTP grant 'Prodrug production through enzymatic glycosylation' (2025-2029, 3.2 million DKK) Novo Nordisk Foundation project grant on time-resolved LPMO studies (2025-2027, 3 million DKK) HALRIC pilot project on time-resolved LPMO studies (2024, ~150K DKK) Radical Innovation Sprint project 'FRESHEN' (2024, ~300K DKK) She currently supervises 1 Postdoc, 1 PhD student, 1 guest PhD student, 1 Research assistant, 3 MSc students, and 2 BSc students. Previously, she has supervised 9 Postdocs, 10 PhD students, 28 M.Sc. students, 14 B.Sc. students, and numerous other research students and assistants. Professor Lo Leggio leads research within the ISBUC Structural Biology cluster and the Medicinal Chemistry cluster at the University of Copenhagen. Her laboratory combines structural biology techniques with biochemical and biophysical approaches to investigate enzyme mechanisms. Her team collaborates internationally on projects related to biomass conversion, enzyme engineering, and sustainable biotechnology applications.
Ieva Bagdonaite is an Assistant Professor in the Department of Cellular and Molecular Medicine at the University of Copenhagen, where she is part of the Glycomics Program. Her research focuses on understanding how glycans influence cellular and organismal biology. Her research interests include: Glycobiology and glycomics Host-pathogen interactions involving viruses Cancer biology related to glycosylation Tissue differentiation and epithelial formation Organotypic tissue modeling Mass spectrometry applications in glycoproteomics Dr. Bagdonaite's recent publications demonstrate a strong focus on the intersection of glycobiology and virology, particularly examining how glycans influence viral infections including Ebola, HSV-1, and SARS-CoV-2. Her work also extends to cancer biology and tissue development, showing the broad relevance of glycosylation in multiple biological processes. Her research employs gene editing, organotypic tissue models, and sophisticated mass spectrometry to decipher glycan functions. Her scientific contributions have been widely recognized, with several publications receiving significant attention across social media platforms, news outlets, and academic networks, including coverage by multiple news outlets, references in patents, and mentions on Wikipedia. Dr. Bagdonaite leads research in the Wandall Group, where her team aims to exploit glycan knowledge for new and targeted treatments for inflammation, cancer, tissue regeneration, and the development of novel viral vaccine strategies.
Javier Martin Gonzalez serves as a Doctor Research consultant and manager of the Transgenic Core Facility at the University of Copenhagen's Faculty of Health and Medical Sciences. With expertise in genetic modification and mouse model development, he leads a critical research support unit that provides essential services to the scientific community. His research interests center on genetic modification techniques, particularly CRISPR/Cas9 applications, mouse model development, embryonic stem cell culture and modification, and assisted reproduction technologies. The Transgenic Core Facility maintains an extensive cryobank with over 750 mouse strains, supporting researchers through embryo manipulation, stem cell derivation, and specialized breeding programs. His recent publication record demonstrates a strong focus on developmental biology, genome editing, and reproductive science, with multiple high-impact publications in 2024-2025 across journals including Cell Reports, Nature Communications, and Heliyon. His work spans from fundamental DNA repair mechanisms to applications in fertility and embryonic development. The Transgenic Core Facility under his management represents a vital resource for researchers at the University of Copenhagen, providing specialized expertise in mouse model generation and maintenance that supports numerous research projects across the institution.
